-
1
-
-
39749191084
-
Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
-
(2008)
Circulation
, vol.117
-
-
Rosamond, W.1
Flegal, K.2
Furie, K.3
Go, A.4
Greenlund, K.5
Haase, N.6
-
2
-
-
58849105951
-
Hospital readmissions and death from heart failure-rates still alarming
-
Barretto A.C.P., Carlo C.H.D., Cardoso J.N., Morgado P.C., Munhoz R.T., Eid M.O., et al. Hospital readmissions and death from heart failure-rates still alarming. Arq Bras Cardiol 91 (2008) 309-314
-
(2008)
Arq Bras Cardiol
, vol.91
, pp. 309-314
-
-
Barretto, A.C.P.1
Carlo, C.H.D.2
Cardoso, J.N.3
Morgado, P.C.4
Munhoz, R.T.5
Eid, M.O.6
-
3
-
-
0030226423
-
Basic mechanisms in heart failure: the cytokine hypothesis
-
Seta Y., Shan K., Bozkurt B., Oral H., and Mann D.L. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 2 (1996) 243-249
-
(1996)
J Card Fail
, vol.2
, pp. 243-249
-
-
Seta, Y.1
Shan, K.2
Bozkurt, B.3
Oral, H.4
Mann, D.L.5
-
4
-
-
38549102037
-
Cytokines and myocardial dysfunction: state of the art
-
El-Menyar A.A. Cytokines and myocardial dysfunction: state of the art. J Card Fail 14 (2008) 61-74
-
(2008)
J Card Fail
, vol.14
, pp. 61-74
-
-
El-Menyar, A.A.1
-
5
-
-
0033614672
-
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
-
Niebauer J., Volk H.D., Kemp M., Dominguez M., Schumann R.R., Rauchhaus M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353 (1999) 1838-1842
-
(1999)
Lancet
, vol.353
, pp. 1838-1842
-
-
Niebauer, J.1
Volk, H.D.2
Kemp, M.3
Dominguez, M.4
Schumann, R.R.5
Rauchhaus, M.6
-
6
-
-
1642463859
-
Inflammatory mediators in chronic heart failure: an overview
-
Anker S.D., and von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 90 (2004) 464-470
-
(2004)
Heart
, vol.90
, pp. 464-470
-
-
Anker, S.D.1
von Haehling, S.2
-
7
-
-
0035942264
-
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)
-
Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
-
(2001)
Circulation
, vol.103
, pp. 2055-2059
-
-
Deswal, A.1
Petersen, N.J.2
Feldman, A.M.3
Young, J.B.4
White, B.G.5
Mann, D.L.6
-
8
-
-
0038755661
-
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
-
Chung E.S., Packer M., Lo K.H., Fasanmade A.A., and Willerson J.T. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107 (2003) 3133-3140
-
(2003)
Circulation
, vol.107
, pp. 3133-3140
-
-
Chung, E.S.1
Packer, M.2
Lo, K.H.3
Fasanmade, A.A.4
Willerson, J.T.5
-
9
-
-
11144355760
-
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
-
Mann D.L., McMurray J.J., Packer M., Swedberg K., Borer J.S., Colucci W.S., et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109 (2004) 1594-1602
-
(2004)
Circulation
, vol.109
, pp. 1594-1602
-
-
Mann, D.L.1
McMurray, J.J.2
Packer, M.3
Swedberg, K.4
Borer, J.S.5
Colucci, W.S.6
-
10
-
-
3242810591
-
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial
-
Anand I., McMurray J., Cohn J.N., Konstam M.A., Notter T., Quitzau K., et al. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 347-354
-
(2004)
Lancet
, vol.364
, pp. 347-354
-
-
Anand, I.1
McMurray, J.2
Cohn, J.N.3
Konstam, M.A.4
Notter, T.5
Quitzau, K.6
-
11
-
-
33745282396
-
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial
-
Hudson M.P., Armstrong P.W., Ruzyllo W., Brum J., Cusmano L., Krzeski P., et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol 48 (2006) 15-20
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 15-20
-
-
Hudson, M.P.1
Armstrong, P.W.2
Ruzyllo, W.3
Brum, J.4
Cusmano, L.5
Krzeski, P.6
-
12
-
-
0036849035
-
Effect of thalidomide in patients with chronic heart failure
-
Gullestad L., Semb A.G., Holt E., Skardal R., Ueland T., Yndestad A., et al. Effect of thalidomide in patients with chronic heart failure. Am Heart J 144 (2002) 847-850
-
(2002)
Am Heart J
, vol.144
, pp. 847-850
-
-
Gullestad, L.1
Semb, A.G.2
Holt, E.3
Skardal, R.4
Ueland, T.5
Yndestad, A.6
-
13
-
-
1242314227
-
Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study
-
Sliwa K., Woodiwiss A., Kone V.N., Candy G., Badenhorst D., Norton G., et al. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation 109 (2004) 750-755
-
(2004)
Circulation
, vol.109
, pp. 750-755
-
-
Sliwa, K.1
Woodiwiss, A.2
Kone, V.N.3
Candy, G.4
Badenhorst, D.5
Norton, G.6
-
14
-
-
29144481887
-
The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure
-
Gong K., Zhang Z., Sun X., Zhang X., Li A., Yan J., et al. The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure. Am Heart J 151 (2006) 62-68
-
(2006)
Am Heart J
, vol.151
, pp. 62-68
-
-
Gong, K.1
Zhang, Z.2
Sun, X.3
Zhang, X.4
Li, A.5
Yan, J.6
-
15
-
-
0022637441
-
Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide
-
Baggott J., Vaughn W., and Hudson B. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J 236 (1986) 193-200
-
(1986)
Biochem J
, vol.236
, pp. 193-200
-
-
Baggott, J.1
Vaughn, W.2
Hudson, B.3
-
16
-
-
0032518281
-
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides
-
Morabito L., Montesinos M.C., Schreibman D.M., Balter L., Thompson L.F., Resta R., et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 101 (1998) 295-300
-
(1998)
J Clin Invest
, vol.101
, pp. 295-300
-
-
Morabito, L.1
Montesinos, M.C.2
Schreibman, D.M.3
Balter, L.4
Thompson, L.F.5
Resta, R.6
-
17
-
-
0025967399
-
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells
-
Cronstein B.N., Eberle M.A., Gruber H.E., and Levin R.I. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A 88 (1991) 2441
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 2441
-
-
Cronstein, B.N.1
Eberle, M.A.2
Gruber, H.E.3
Levin, R.I.4
-
18
-
-
0027139914
-
The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation
-
Cronstein B.N., Naime D., and Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 92 (1993) 2675-2682
-
(1993)
J Clin Invest
, vol.92
, pp. 2675-2682
-
-
Cronstein, B.N.1
Naime, D.2
Ostad, E.3
-
19
-
-
34447506101
-
Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia
-
Glover D.K., Ruiz M., Takehana K., Petruzella F.D., Rieger J.M., Macdonald T.L., et al. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. Am J Physiol Heart Circ Physiol 292 (2007) H3164-H3171
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
-
-
Glover, D.K.1
Ruiz, M.2
Takehana, K.3
Petruzella, F.D.4
Rieger, J.M.5
Macdonald, T.L.6
-
20
-
-
0034625177
-
Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
-
Marzilli M., Orsini E., Marraccini P., and Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 101 (2000) 2154-2159
-
(2000)
Circulation
, vol.101
, pp. 2154-2159
-
-
Marzilli, M.1
Orsini, E.2
Marraccini, P.3
Testa, R.4
-
21
-
-
0034820335
-
Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting
-
Wei M., Kuukasjarvi P., Laurikka J., Honkonen E.L., Kaukinen S., Laine S., et al. Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting. Chest 120 (2001) 860-865
-
(2001)
Chest
, vol.120
, pp. 860-865
-
-
Wei, M.1
Kuukasjarvi, P.2
Laurikka, J.3
Honkonen, E.L.4
Kaukinen, S.5
Laine, S.6
-
22
-
-
33846419531
-
Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study
-
Lee C.H., Low A., Tai B.C., Co M., Chan M.Y., Lim J., et al. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study. Eur Heart J 28 (2007) 19-25
-
(2007)
Eur Heart J
, vol.28
, pp. 19-25
-
-
Lee, C.H.1
Low, A.2
Tai, B.C.3
Co, M.4
Chan, M.Y.5
Lim, J.6
-
23
-
-
20344394410
-
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)
-
Ross A.M., Gibbons R.J., Stone G.W., Kloner R.A., and Alexander R.W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45 (2005) 1775-1780
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1775-1780
-
-
Ross, A.M.1
Gibbons, R.J.2
Stone, G.W.3
Kloner, R.A.4
Alexander, R.W.5
-
24
-
-
0025937656
-
Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs
-
Kitakaze M., Hori M., Sato H., Takashima S., Inoue M., Kitabatake A., et al. Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 69 (1991) 1402-1408
-
(1991)
Circ Res
, vol.69
, pp. 1402-1408
-
-
Kitakaze, M.1
Hori, M.2
Sato, H.3
Takashima, S.4
Inoue, M.5
Kitabatake, A.6
-
25
-
-
3042666201
-
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts
-
Asanuma H., Sanada S., Ogai A., Minamino T., Takashima S., Asakura M., et al. Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts. J Cardiovasc Pharmacol 43 (2004) 574-579
-
(2004)
J Cardiovasc Pharmacol
, vol.43
, pp. 574-579
-
-
Asanuma, H.1
Sanada, S.2
Ogai, A.3
Minamino, T.4
Takashima, S.5
Asakura, M.6
-
26
-
-
84921431104
-
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
-
CD000951
-
Ortiz Z., Shea B., Suarez Almazor M., Moher D., Wells G., and Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev 2 (2000) CD000951
-
(2000)
Cochrane Database Syst Rev
, vol.2
-
-
Ortiz, Z.1
Shea, B.2
Suarez Almazor, M.3
Moher, D.4
Wells, G.5
Tugwell, P.6
-
27
-
-
0036644465
-
ATS statement: guidelines for the six-minute walk test
-
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 111-117
-
-
-
29
-
-
0034944211
-
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
-
van Ede A.E., Laan R.F., Rood M.J., Huizinga T.W., van de Laar M.A., van Denderen C.J., et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44 (2001) 1515-1524
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1515-1524
-
-
van Ede, A.E.1
Laan, R.F.2
Rood, M.J.3
Huizinga, T.W.4
van de Laar, M.A.5
van Denderen, C.J.6
-
30
-
-
41249095660
-
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
-
Naranjo A., Sokka T., Descalzo M.A., Calvo-Alen J., Horslev-Petersen K., Luukkainen R.K., et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10 (2008) R30
-
(2008)
Arthritis Res Ther
, vol.10
-
-
Naranjo, A.1
Sokka, T.2
Descalzo, M.A.3
Calvo-Alen, J.4
Horslev-Petersen, K.5
Luukkainen, R.K.6
-
31
-
-
0030614436
-
Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence
-
Jordan J.E., Zhao Z.Q., Sato H., Taft S., and Vinten-Johansen J. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 280 (1997) 301-309
-
(1997)
J Pharmacol Exp Ther
, vol.280
, pp. 301-309
-
-
Jordan, J.E.1
Zhao, Z.Q.2
Sato, H.3
Taft, S.4
Vinten-Johansen, J.5
-
32
-
-
36349031175
-
Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations
-
Heck C.I., and de Mejia E.G. Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations. J Food Sci 72 (2007) R138-R151
-
(2007)
J Food Sci
, vol.72
-
-
Heck, C.I.1
de Mejia, E.G.2
-
33
-
-
0037332053
-
Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis
-
Nesher G., Mates M., and Zevin S. Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis. Arthr Rheum 48 (2003) 2
-
(2003)
Arthr Rheum
, vol.48
, pp. 2
-
-
Nesher, G.1
Mates, M.2
Zevin, S.3
-
34
-
-
0021803103
-
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure
-
Guyatt G.H., Sullivan M.J., Thompson P.J., Fallen E.L., Pugsley S.O., Taylor D.W., et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132 (1985) 919-923
-
(1985)
Can Med Assoc J
, vol.132
, pp. 919-923
-
-
Guyatt, G.H.1
Sullivan, M.J.2
Thompson, P.J.3
Fallen, E.L.4
Pugsley, S.O.5
Taylor, D.W.6
-
35
-
-
33745268839
-
Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice
-
Passantino A., Lagioia R., Mastropasqua F., and Scrutinio D. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. J Am Coll Cardiol 48 (2006) 99-105
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 99-105
-
-
Passantino, A.1
Lagioia, R.2
Mastropasqua, F.3
Scrutinio, D.4
-
36
-
-
17444416672
-
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review
-
Olsson L.G., Swedberg K., Clark A.L., Witte K.K., and Cleland J.G. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26 (2005) 778-793
-
(2005)
Eur Heart J
, vol.26
, pp. 778-793
-
-
Olsson, L.G.1
Swedberg, K.2
Clark, A.L.3
Witte, K.K.4
Cleland, J.G.5
-
37
-
-
21744454142
-
Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure
-
Rodriguez-Artalejo F., Guallar-Castillon P., Pascual C.R., Otero C.M., Montes A.O., Garcia A.N., et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med 165 11 (2005) 1274-1279
-
(2005)
Arch Intern Med
, vol.165
, Issue.11
, pp. 1274-1279
-
-
Rodriguez-Artalejo, F.1
Guallar-Castillon, P.2
Pascual, C.R.3
Otero, C.M.4
Montes, A.O.5
Garcia, A.N.6
|